These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16400975)

  • 1. [Heart failure. Current pharmacologic treatment].
    Coma-Canella I; Castaño S; Nasarre E
    Rev Med Univ Navarra; 2005; 49(3):41-7. PubMed ID: 16400975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure.
    Howard PA; Cheng JW; Crouch MA; Colucci VJ; Kalus JS; Spinler SA; Munger M
    Ann Pharmacother; 2006 Sep; 40(9):1607-17. PubMed ID: 16896019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, pathophysiology, prognosis, and treatment of systolic and diastolic heart failure.
    Aronow WS
    Cardiol Rev; 2006; 14(3):108-24. PubMed ID: 16628020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inotropic drugs and neurohormonal antagonists in the treatment of HF in the elderly.
    O'Connor CM; Arumugham P
    Clin Geriatr Med; 2007 Feb; 23(1):141-53. PubMed ID: 17126759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triple/quadruple therapy in heart failure: integrating scientific evidence with clinical reasoning].
    Sinagra G; Sabbadini G; Zecchin M; Di Lenarda A
    G Ital Cardiol (Rome); 2007 Sep; 8(9):559-67. PubMed ID: 17972425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heart failure with abnormal left ventricular systolic function in the elderly.
    Aronow WS
    Clin Geriatr Med; 2007 Feb; 23(1):61-81. PubMed ID: 17126755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The lessons from clinical trials in congestive heart failure].
    Anguita Sánchez M
    Rev Esp Cardiol; 1995 Nov; 48(11):699-709. PubMed ID: 8532939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
    Norgard NB; Stark JE
    Pharmacotherapy; 2008 Jul; 28(7):920-31. PubMed ID: 18576907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
    Brackbill ML; Bashaw-Keaton R; Sytsma CS
    Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of chronic heart failure according to the 2005 guidelines of the European Society of Cardiology.
    Voors AA; van Veldhuisen DJ
    Minerva Cardioangiol; 2005 Aug; 53(4):233-9. PubMed ID: 16177668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.
    Jorde UP
    Cardiol Rev; 2006; 14(2):81-7. PubMed ID: 16493245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
    Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
    Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
    Setoguchi S; Levin R; Winkelmayer WC
    Int J Cardiol; 2008 Apr; 125(2):172-7. PubMed ID: 17997175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.